Hosted on MSN3d
EMA approves Sanofi/Regeneron’s Dupixent for young EoE patients
The safety results from the EoE KIDS study were consistent with the known safety profile of Dupixent in adolescents and ...
FiercePharma2d
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
Dallas Morning News on MSN2d
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...
Inverse12d
The Medicines We Take Don’t All Break Down In Our Bodies — They End Up Here Instead
Modern pharmaceuticals have revolutionised disease prevention and treatment. But eventually, the chemicals can end up in rivers, oceans and soils.
EURACTIV5d
European Patients’ Forum developing new patient involvement barometer to improve healthcare
Patient involvement in health policy is a patchwork across the EU. Putting the lived experience front and centre of policy-making was prioritised at a recent high-level policy event organised by the ...
EU Critical Medicines Act: closer to ending overreliance on Asian manufacturers
China's virtual monopoly on the supply of many APIs could be dangerous for the security of medicine supply to Western ...
Novinite3d
Hungarian European Commissioner Nominee Faces Further Scrutiny After Unfavorable Hearing
The MEPs also criticized Varhelyi over Hungary’s use of the Russian-made Sputnik vaccine during the COVID-19 pandemic, alongside vaccines approved by the European Medicines Agency. He responded by ...